Similarly, bioactive modified secondary BAs, including isodeoxycholic acid, alloisoLCA, and 3-oxoLCA, were found at lower concentrations with more advanced liver disease, and this correlates with HSDH and reductase gene encoding (Figure A6). The gene discussed is SDS; the disease is liver disorder.